Reference : Cost-effectiveness of Denosumab compared with generic alendronate in the treatment of po...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : Rheumatology
Human health sciences : Public health, health care sciences & services
Business & economic sciences : Special economic topics (health, labor, transportation…)
http://hdl.handle.net/2268/88517
Cost-effectiveness of Denosumab compared with generic alendronate in the treatment of postmenopausal osteoporotic women
English
Hiligsmann, Mickaël mailto [Université de Liège - ULg > Département des sciences de la santé publique & HEC-Ecole de Gestion > > >]
Reginster, Jean-Yves mailto [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Mar-2011
Osteoporosis International
Springer Science & Business Media B.V.
22
Suppl.1
S112-113
Yes (verified by ORBi)
No
International
0937-941X
1433-2965
Godalming
United Kingdom
European Congress on Osteoporosis and Osteoarthritis ECCEO11-IOF
du 23 mars 2011 au 26 mars 2011
International Osteoporosis Foundation and National Osteoporosis Foundation 2011
Valencia
Spain
http://hdl.handle.net/2268/88517

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
OC36.pdfPublisher postprint60.71 kBRequest copy

Additional material(s):

File Commentary Size Access
Restricted access
OC36.pdfCommunication orale368.19 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.